Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Trading Statement

12 Oct 2021 07:00

RNS Number : 7171O
De La Rue PLC
12 October 2021
 

12 October 2021

 

DE LA RUE PLC

TRADING UPDATE

De La Rue plc (LSE: DLAR) ("De La Rue", or "the Company") today announces a trading update for the six months ended 25 September 2021.

Trading in both our Currency and Authentication divisions for the first half has been positive, with our Turnaround Plan and cost reduction activities continuing to strengthen the Company's performance versus the similar period in financial years 2019/20 and 2020/21. The outlook for the financial year 2021/22 continues to be in line with the Board's expectations.

Net debt at the half year was lower than expected, and less than at the end of the financial year 2020/21. This was as a result of both the phasing of capital expenditure and strong cash collections. The outlook for net debt for the full year is in line with the Board's expectations.

De La Rue expects to announce its results for the six months ended 25 September 2021 on 24 November 2021.

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

Enquiries:

De La Rue plc

 

+44 (0) 7387 122645

 

Clive Vacher

 

Chief Executive Officer

 

Rob Harding

 

Chief Financial Officer

 

Matthew Rose

 

Director of Tax, Treasury and Investor Relations

 

Kirstie Thomas

 

Investor Relations Manager

 

 

 

 

 

Brunswick

 

+44 (0)207 404 5959

 

Stuart Donnelly

 

Ed Brown

 

 

 

Cautionary note regarding forward-looking statements

 

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "plans", "goal", "target", "aim", "may", "will", "would", "could" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the directors, De La Rue or the Group concerning, amongst other things, the results of operations, profitability, financial condition, liquidity, prospects, growth and strategies of De La Rue and the industry in which it operates.

 

By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond De La Rue's ability to control or predict. Forward-looking statements are not guarantees of future performance. The Group's actual results of operations, profitability, financial condition, liquidity, prospects, growth and/or strategy and the development of the industry in which it operates may differ materially from the impression created by the forward-looking statements contained in this announcement. In addition, even if the results of operations, profitability, financial condition, liquidity, prospects, growth and/or strategy of the Group and the development of the industry in which it operates are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods.

 

Other than in accordance with its legal or regulatory obligations, De La Rue does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMBBFTMTIBBAB
Date   Source Headline
9th Jul 20201:38 pmRNSHolding(s) in Company
8th Jul 20203:58 pmRNSDirector/PDMR Shareholding
6th Jul 20202:20 pmRNSResults of Capital Raising and General Meeting
3rd Jul 20202:31 pmRNSHolding(s) in Company
2nd Jul 20205:46 pmRNSHolding(s) in Company
1st Jul 202010:46 amRNSBlock listing Interim Review
23rd Jun 202011:48 amRNSHolding(s) in Company
17th Jun 20202:15 pmRNSPublication of Prospectus
17th Jun 20207:01 amRNSProposed Capital Raising
17th Jun 20207:00 amRNS2019/20 FULL YEAR RESULTS AND ANNUAL REPORT 2020
16th Jun 20207:00 amRNSSFO INVESTIGATION CLOSURE
1st Jun 20207:00 amRNSTRADING AND COVID-19 UPDATE
6th May 20207:00 amRNSFULL YEAR ANNOUNCEMENT DATE
27th Apr 20205:57 pmRNSDisclosure of Rights Attached to Equity Shares
1st Apr 202012:28 pmRNSTotal Voting Rights
31st Mar 20207:00 amRNSTrading Update
27th Mar 20209:31 amRNSHolding(s) in Company
24th Mar 202010:35 amRNSHolding(s) in Company
9th Mar 20205:28 pmRNSHolding(s) in Company
5th Mar 20205:44 pmRNSHolding(s) in Company
25th Feb 20205:48 pmRNSHolding(s) in Company
25th Feb 20207:00 amRNSTURNAROUND AND TRADING UPDATE
10th Feb 20202:00 pmRNSCHIEF FINANCIAL OFFICER APPOINTMENT
4th Feb 20206:05 pmRNSDirector Declaration
3rd Feb 20202:38 pmRNSTotal Voting Rights
29th Jan 20203:53 pmRNSHolding(s) in Company
24th Jan 202010:44 amRNSDirectorate Change
7th Jan 20205:13 pmRNSHolding(s) in Company
7th Jan 20205:09 pmRNSDirector/PDMR Shareholding
7th Jan 20205:05 pmRNSDirector/PDMR Shareholding
6th Jan 20204:58 pmRNSHolding(s) in Company
2nd Jan 202010:58 amRNSBlock listing Interim Review
2nd Jan 202010:52 amRNSTotal Voting Rights
19th Dec 20192:58 pmRNSDirector/PDMR Shareholding
16th Dec 201912:46 pmRNSDirector/PDMR Shareholding
4th Dec 20196:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20193:36 pmRNSHolding(s) in Company
2nd Dec 201910:07 amRNSTotal Voting Rights
29th Nov 20192:09 pmRNSDirector/PDMR Shareholding
28th Nov 20194:20 pmRNSDirector/PDMR Shareholding
26th Nov 20196:44 pmRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNS2019/20 HALF YEAR RESULTS
21st Nov 20193:00 pmRNSAdditional Listing
13th Nov 20193:03 pmRNSHolding(s) in Company
8th Nov 20194:56 pmRNSHolding(s) in Company
31st Oct 20195:05 pmRNSTotal Voting Rights
30th Oct 20197:00 amRNSTrading Update
14th Oct 20193:59 pmRNSCompletion of Sale of ID Business
7th Oct 20195:53 pmRNSHolding(s) in Company
7th Oct 20194:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.